KLRAQ1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.133970E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.111400E-01
Normal-vs-Stage2
9.634300E-02
Normal-vs-Stage3
5.353800E-02
Normal-vs-Stage4
9.880000E-01
Stage1-vs-Stage2
3.710600E-01
Stage1-vs-Stage3
6.521600E-03
Stage1-vs-Stage4
2.082200E-01
Stage2-vs-Stage3
4.411500E-02
Stage2-vs-Stage4
4.965900E-02
Stage3-vs-Stage4
4.761900E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.302250E-01
Normal-vs-AfricanAmerican
2.986600E-01
Normal-vs-Asian
5.970000E-02
Caucasian-vs-AfricanAmerican
9.267600E-01
Caucasian-vs-Asian
1.071760E-01
AfricanAmerican-vs-Asian
2.525600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.168250E-01
Normal-vs-Female
1.306220E-01
Male-vs-Female
8.375200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.405600E-01
Normal-vs-Age(41-60Yrs)
1.892990E-01
Normal-vs-Age(61-80Yrs)
1.126950E-01
Normal-vs-Age(81-100Yrs)
3.159800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.272200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.829800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.838200E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.255700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.013560E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.491400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.799700E-02
Normal-vs-Daily Drinker
1.015440E-01
Normal-vs-Weekly Drinker
2.022400E-01
Normal-vs-Occasional Drinker
3.654800E-01
Normal-vs-Social Drinker
2.770800E-01
Non Drinker-vs-Daily Drinker
6.856800E-01
Non Drinker-vs-Weekly Drinker
8.058800E-01
Non Drinker-vs-Occasional Drinker
5.593800E-02
Non Drinker-vs-Social Drinker
1.073020E-01
Daily Drinker-vs-Weekly Drinker
9.488200E-01
Daily Drinker-vs-Occasional Drinker
1.626430E-01
Daily Drinker-vs-Social Drinker
2.581400E-01
Weekly Drinker-vs-Occasional Drinker
2.501600E-01
Weekly Drinker-vs-Social Drinker
3.484600E-01
Occasional Drinker-vs-Social Drinker
8.036800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.975900E-02
Normal-vs-Grade 2
4.916600E-03
Normal-vs-Grade 3
3.703900E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.185400E-01
Grade 1-vs-Grade 3
4.188000E-01
Grade 1-vs-Grade 4
6.975900E-02
Grade 2-vs-Grade 3
7.452000E-01
Grade 2-vs-Grade 4
4.916600E-03
Grade 3-vs-Grade 4
3.703900E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.916200E-02
Normal-vs-NonDiabetic
7.974100E-02
Diabetic-vs-NonDiabetic
6.183000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.413700E-02
Normal-vs-NoPancreatitis
9.500200E-02
Pancreatitis-vs-NoPancreatitis
4.350200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.176000E-01
Normal-vs-N1
9.561600E-02
N0-vs-N1
4.292600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.584010E-01
Normal-vs-TP53-NonMutant
2.943400E-01
TP53-Mutant-vs-TP53-NonMutant
9.731200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
